Clinical ophthalmology (Auckland, N.Z.) · 2025
The Correlation Between Macular Vessel Density and Its Clinical Parameters in Diabetes Mellitus Type 2.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dewi Nadia Artha, Arfan Muhammad, Rahmasari Herisa, Putri Mutiara Kristiani, Rosandi Rulli
Аннотация
PURPOSE: To evaluate macular vessel density using clinical parameters in patients with type 2 diabetes mellitus (DM) without retinopathy.
PATIENTS AND METHODS: This cross-sectional study enrolled 32 participants (63 eyes) aged 40-60 years who met the inclusion criteria. Group 1 included 32 eyes of type 2 DM, whereas the rest had no DM. Ophthalmic examination was performed. Macular vessel density was measured using optical coherence tomography angiography (OCTA) with a 6 × 6 mm scan. Macular vessel density is correlated with patient age, HbA1c values, disease duration, and contrast sensitivity. The data were analyzed using Spearman's rank correlation and an independent t-test.
RESULTS: Central (foveal area) macular vessel density in the diabetic group (5.36 ± 2.87) was significantly lower than that in healthy participants (7.82 ± 3.05) (p = 0.002). The whole macular vessel density (foveal and parafoveal areas) was also lower in the DM group than in the healthy subjects (15.76 ± 3.38 vs 17.18 ± 1.92) but the difference was not statistically significant (p = 0.070). The age of DM patients has correlated with central (r = -0.522; p = 0.002) and whole macular vessel density (r = -0.369; p = 0.038). HbA1c levels, diabetes duration, and contrast sensitivity were not correlated with macular vessel density.
CONCLUSION: Macular vessel density was lower in DM patients without retinopathy than in healthy subjects. In patients with DM, macular vessel density decreases with increasing age. We failed to find a correlation between macular vessel density and the HbA1c value, disease duration, or contrast sensitivity.
PATIENTS AND METHODS: This cross-sectional study enrolled 32 participants (63 eyes) aged 40-60 years who met the inclusion criteria. Group 1 included 32 eyes of type 2 DM, whereas the rest had no DM. Ophthalmic examination was performed. Macular vessel density was measured using optical coherence tomography angiography (OCTA) with a 6 × 6 mm scan. Macular vessel density is correlated with patient age, HbA1c values, disease duration, and contrast sensitivity. The data were analyzed using Spearman's rank correlation and an independent t-test.
RESULTS: Central (foveal area) macular vessel density in the diabetic group (5.36 ± 2.87) was significantly lower than that in healthy participants (7.82 ± 3.05) (p = 0.002). The whole macular vessel density (foveal and parafoveal areas) was also lower in the DM group than in the healthy subjects (15.76 ± 3.38 vs 17.18 ± 1.92) but the difference was not statistically significant (p = 0.070). The age of DM patients has correlated with central (r = -0.522; p = 0.002) and whole macular vessel density (r = -0.369; p = 0.038). HbA1c levels, diabetes duration, and contrast sensitivity were not correlated with macular vessel density.
CONCLUSION: Macular vessel density was lower in DM patients without retinopathy than in healthy subjects. In patients with DM, macular vessel density decreases with increasing age. We failed to find a correlation between macular vessel density and the HbA1c value, disease duration, or contrast sensitivity.